Appeal 2006-3083
Application 10/121,634
DISCUSSION
1. CLAIMS
Claims 1-17 are pending and on appeal. Claim 1 is representative and
reads as follows:
1. An occlusive composition comprising: a) a poly(2-
cyanoacrylate) monomer of the following formula (I):
wherein n≥2, and R is an organic moiety, and b) a visualization agent.
Thus, claim 1 is directed to a composition comprising a visualization
agent and a poly(2-cyanoacrylate) monomer. The poly(2-cyanoacrylate)
monomer is defined by a chemical formula, which requires that an organic
moiety (R) have two or more 2-cyanoacrylate groups attached to it.
2. PRIOR ART
The Examiner relies on the following references:
Krall US 6,538,026 B1 Mar. 25, 2003
Yin-Chao Tseng et al., “Modified ethoxyethyl cyanoacrylate for
therapeutic embolization of arteriovenous malformation,” 24 Journal of
Biomedical Materials Research 65-77 (1990).
3. ANTICIPATION
Claims 1-4 and 10-17 stand rejected under 35 U.S.C. § 102(e) as
anticipated by Krall. Claims 1-5 and 13-16 stand rejected under 35 U.S.C.
3
Page: Previous 1 2 3 4 5 6 Next
Last modified: September 9, 2013